The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

NCT00006279 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Nevirapine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)